Giovanni Barillari

Udine, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 98 publications

Pleural effusion as a mortality predictor for acute pulmonary embolism.

Pleural effusion as a mortality predictor for acute pulmonary embolism.

Journal: Research and practice in thrombosis and haemostasis
Published: April 01, 2026

Single-cell profiling reveals a novel CAF subpopulation linking stromal heterogeneity to immune suppression in breast cancer subtypes.

Single-cell profiling reveals a novel CAF subpopulation linking stromal heterogeneity to immune suppression in breast cancer subtypes.

Journal: Journal of translational medicine
Published: February 22, 2026

A serologic weak D expressed by a combined weak D type 1/41.0.1 allele.

A serologic weak D expressed by a combined weak D type 1/41.0.1 allele.

Journal: Transfusion
Published: February 06, 2026

Integrating Clinical, Functional, and Patient-Reported Outcomes in Haemophilia Care: A Delphi-Based Consensus on a New Monitoring Tool.

Integrating Clinical, Functional, and Patient-Reported Outcomes in Haemophilia Care: A Delphi-Based Consensus on a New Monitoring Tool.

Journal: Journal of clinical medicine
Published: December 18, 2025

Fibronectin Is a Likely Therapeutic Target Shared by Oral and Breast Carcinomas.

Fibronectin Is a Likely Therapeutic Target Shared by Oral and Breast Carcinomas.

Journal: International journal of molecular sciences
Published: November 28, 2025

Clinical Characteristics and Impact of May-Thurner Syndrome in Patients With Proximal Deep Vein Thrombosis: Insights From the RIETE Registry.

Clinical Characteristics and Impact of May-Thurner Syndrome in Patients With Proximal Deep Vein Thrombosis: Insights From the RIETE Registry.

Journal: Angiology
Published: November 20, 2025

Lactate-mediated NK cell dysfunction as a prognostic marker and therapeutic target in breast cancer.

Lactate-mediated NK cell dysfunction as a prognostic marker and therapeutic target in breast cancer.

Journal: Cell death discovery
Published: November 10, 2025

Mapping B cells and the immune landscape of tertiary lymphoid structures reveals their clinical impact in neuroblastoma.

Mapping B cells and the immune landscape of tertiary lymphoid structures reveals their clinical impact in neuroblastoma.

Journal: Journal for immunotherapy of cancer
Published: October 21, 2025

Inhibition of bromodomain and extra-terminal motif (BET) proteins in pediatric sarcoma: A systematic review of in vitro and in vivo studies.

Inhibition of bromodomain and extra-terminal motif (BET) proteins in pediatric sarcoma: A systematic review of in vitro and in vivo studies.

Journal: Drug discovery today
Published: August 19, 2025

Multi-omics analyses identify EZH2 as a central driver in rhabdomyosarcoma radioresistance and highlight Tazemetostat as an effective radiosensitizer in vitro and in vivo.

Multi-omics analyses identify EZH2 as a central driver in rhabdomyosarcoma radioresistance and highlight Tazemetostat as an effective radiosensitizer in vitro and in vivo.

Journal: Cell death & disease
Published: July 11, 2025

Neonatal alloimmune thrombocytopenia due to anti-HPA-1b and anti-HLA antibodies: diagnostic and transfusion management of a clinical case.

Neonatal alloimmune thrombocytopenia due to anti-HPA-1b and anti-HLA antibodies: diagnostic and transfusion management of a clinical case.

Journal: Blood transfusion = Trasfusione del sangue
Published: July 02, 2025

The HIV Protease Inhibitor Ritonavir Reverts the Mesenchymal Phenotype Induced by Inflammatory Cytokines in Normal and Tumor Oral Keratinocytes to an Epithelial One, Increasing the Radiosensitivity of Tumor Oral Keratinocytes.

The HIV Protease Inhibitor Ritonavir Reverts the Mesenchymal Phenotype Induced by Inflammatory Cytokines in Normal and Tumor Oral Keratinocytes to an Epithelial One, Increasing the Radiosensitivity of Tumor Oral Keratinocytes.

Journal: Cancers
Published: June 24, 2025
Showing 1-12 of 98

Last Updated: 09/26/2026